Emil D. Kakkis, President & CEO: Ultragenyx Pharmaceutical RARE Sell · Filed 03/03

Trade details

Type: Insider sale
Amount: $1,240,411.2
Shares · price: 54,404 sh · $22.80 a share
Held after: 658,994 sh
Stock: Ultragenyx Pharmaceutical RARE
Person: Emil D. KakkisPresident & CEO
Trade date: 26/03/02
Filed: 26/03/03
Days to filing: 1 days

Sold 7.6% of holdings

Share of holding sold: 7.6%

Ultragenyx Pharmaceutical trades, last 26 weeks

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 01/31~04/01

Emil D. Kakkis's recent trades

Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$3.1M
73,434 sh
$3.1M
Filed 25/03/04
Traded 25/03/03
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$1.1M
25,000 sh
$1.1M
Filed 25/03/04
Traded 25/02/28
Emil D. KakkisOfficer
Planned sale10b5-1 planUltragenyx Pharmaceutical
Planned sale10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$1.1M
25,000 sh
$1.1M
Filed 25/02/28
Traded 25/02/28
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$495.2K
11,727 sh
$495.2K
Filed 24/12/31
Traded 24/12/30
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$413.7K
8,273 sh
$413.7K
Filed 24/12/11
Traded 24/12/10